Searchable abstracts of presentations at key conferences in endocrinology

ea0012oc3 | Young Endocrinologist prize session | SFE2006

Co-administration of SR141716 with peptide YY or oxyntomodulin has additive effects on food intake in mice

White NE , Dhillo WS , Small CJ , Lui YL , Gardiner JV , Ghatei MA , Bloom SR

BackgroundSR141716 (Rimonabant) has been shown to significantly inhibit food intake and reduce body weight in rodents and humans by antagonising CB1 receptors. The gut hormones peptide YY3–36 (PYY3–36) and oxyntomodulin (OXM), released from L-cells in the small intestine inhibit food intake in both rodents and humans and this effect is thought to be mediated via the hypothalamus.Objective<...

ea0008oc9 | Neuroendocrinology and Reproduction | SFE2004

Triiodothyronine Directly Regulates Feeding

Martin NM , Kong WM , Smith KL , Gardiner JV , Small CJ , Ghatei MA , Bloom SR

The increased appetite associated with hyperthyroidism is assumed to be secondary to an increased metabolic rate. However, the role of thyroid hormones in appetite regulation is poorly understood. We hypothesised that thyroid hormones directly regulate food intake and studied the effects of peripheral and CNS administration of tri-iodothyronine (T3) on food intake in male Wistar rats in vivo.A single subcutaneous (s.c.) injection of 4.5 nmol per ...